Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

13.23
+0.13000.99%
Post-market: 13.230.00000.00%19:16 EDT
Volume:410.78K
Turnover:5.39M
Market Cap:205.26M
PE:-4.15
High:13.28
Open:13.00
Low:12.90
Close:13.10
52wk High:16.77
52wk Low:11.95
Shares:15.52M
Float Shares:11.14M
Volume Ratio:0.63
T/O Rate:3.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1910
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:-3.27
PE(LYR):-4.15

Loading ...

Baijin Life Science Enters Strategic Partnership to Advance RNA Technology

TIPRANKS
·
Nov 19, 2025

Mirxes Partners with Walvax to Advance RNA-Centric Precision Medicine

TIPRANKS
·
Nov 18, 2025

MIRXES-B (02629) Signs MOU with Watson to Establish RNA-Centric Preventive and Precision Medicine Platform

Stock News
·
Nov 18, 2025

Circio Holding ASA to Present Latest circVec RNA Platform Results in Upcoming Webcast

TIPRANKS
·
Nov 17, 2025

Hold Rating on Avidity Biosciences Amid Novartis Acquisition and Strategic Developments

TIPRANKS
·
Nov 12, 2025

Chardan Capital Reaffirms Their Hold Rating on Avidity Biosciences (RNA)

TIPRANKS
·
Nov 12, 2025

Wave Life Sciences: Advancements in RNA Medicines Strengthen Buy Rating

TIPRANKS
·
Nov 11, 2025

Avidity Biosciences Is Maintained at Neutral by Chardan Capital

Dow Jones
·
Nov 11, 2025

Hold Rating on Avidity Biosciences Amid Novartis Acquisition Uncertainty

TIPRANKS
·
Nov 11, 2025

Avidity Biosciences Reports Increased Revenue Amid Losses

TIPRANKS
·
Nov 11, 2025

Avidity Biosciences Q3 EPS $(1.27) Misses $(1.11) Estimate, Sales $12.475M Beat $1.932M Estimate

Benzinga
·
Nov 11, 2025

Avidity Biosciences reports wider-than-expected Q3 net loss

Reuters
·
Nov 11, 2025

SanegeneBio announces RNAi licensing, collaboration with Lilly

TIPRANKS
·
Nov 10, 2025

Wave Life Sciences to Present at Upcoming Investor Conferences

GlobeNewswire
·
Nov 07, 2025

Chardan Downgrades Avidity Biosciences to Neutral From Buy

MT Newswires Live
·
Nov 07, 2025

Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia

GlobeNewswire
·
Nov 06, 2025

ProQR Announces Third Quarter 2025 Operating and Financial Results

GlobeNewswire
·
Nov 06, 2025

Stoke Therapeutics Advances in RNA Medicine and Financial Growth

TIPRANKS
·
Nov 05, 2025

Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025

GlobeNewswire
·
Nov 04, 2025

Dexerials, Veritas In Silico to Develop High-Speed RNA Structure Analysis Technology

MT Newswires Live
·
Nov 04, 2025